A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. [electronic resource]
Producer: 20060123Description: 65-74 p. digitalISSN:- 1470-0328
- Administration, Oral
- Adult
- Anti-Infective Agents -- therapeutic use
- Biomarkers -- analysis
- Birth Weight
- Cervix Uteri -- chemistry
- Double-Blind Method
- Female
- Fibronectins -- analysis
- Gestational Age
- Glycoproteins -- analysis
- Humans
- Metronidazole -- therapeutic use
- Obstetric Labor, Premature -- prevention & control
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Pregnancy Outcome
- Risk Factors
- Tocolytic Agents -- therapeutic use
- Vagina -- chemistry
- Vaginosis, Bacterial -- drug therapy
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.